skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: MRI Assessment of Uterine Artery Patency and Fibroid Infarction Rates 6 Months after Uterine Artery Embolization with Nonspherical Polyvinyl Alcohol

Journal Article · · Cardiovascular and Interventional Radiology
; ;  [1];  [2];  [1]
  1. St George's Healthcare NHS Trust, Blackshaw, Department of Radiology (United Kingdom)
  2. St George's Healthcare NHS Trust, Department of Gynaecology (United Kingdom)

Purpose: We have observed significant rates of uterine artery patency after uterine artery embolization (UAE) with nonspherical polyvinyl alcohol (nsPVA) on 6 month follow-up MR scanning. The study aim was to quantitatively assess uterine artery patency after UAE with nsPVA and to assess the effect of continued uterine artery patency on outcomes. Methods: A single centre, retrospective study of 50 patients undergoing bilateral UAE for uterine leiomyomata was undertaken. Pelvic MRI was performed before and 6 months after UAE. All embolizations were performed with nsPVA. Outcome measures included uterine artery patency, uterine and dominant fibroid volume, dominant fibroid percentage infarction, presence of ovarian arterial collaterals, and symptom scores assessed by the Uterine Fibroid Symptom and Quality of Life questionnaire (UFS-QOL). Results: Magnetic resonance angiographic evidence of uterine artery recanalization was demonstrated in 90 % of the patients (64 % bilateral, 26 % unilateral) at 6 months. Eighty percent of all dominant fibroids demonstrated >90 % infarction. The mean percentage reduction in dominant fibroid volume was 35 %. No significant difference was identified between nonpatent, unilateral, and bilateral recanalization of the uterine arteries with regard to percentage dominant fibroid infarction or dominant fibroid volume reduction. The presence of bilaterally or unilaterally patent uterine arteries was not associated with inferior clinical outcomes (symptom score or UFS-QOL scores) at 6 months. Conclusion: The high rates of uterine artery patency challenge the current paradigm that nsPVA is a permanent embolic agent and that permanent uterine artery occlusion is necessary to optimally treat uterine fibroids. Despite high rates of uterine artery recanalization in this cohort, satisfactory fibroid infarction rates and UFS-QOL scores were achieved.

OSTI ID:
22208014
Journal Information:
Cardiovascular and Interventional Radiology, Vol. 36, Issue 5; Other Information: Copyright (c) 2013 Springer Science+Business Media New York and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE); http://www.springer-ny.com; Country of input: International Atomic Energy Agency (IAEA); ISSN 0174-1551
Country of Publication:
United States
Language:
English

Similar Records

Ovarian Artery Embolization in Patients With Collateral Supply to Symptomatic Uterine Leiomyomata
Journal Article · Thu Dec 15 00:00:00 EST 2011 · Cardiovascular and Interventional Radiology · OSTI ID:22208014

Initial Experience of Uterine Fibroid Embolization Using Porous Gelatin Sponge Particles
Journal Article · Wed Jun 15 00:00:00 EDT 2011 · Cardiovascular and Interventional Radiology · OSTI ID:22208014

Uterine Artery Embolization in Women with Symptomatic Cervical Leiomyomata: Efficacy and Safety
Journal Article · Fri Mar 15 00:00:00 EDT 2019 · Cardiovascular and Interventional Radiology · OSTI ID:22208014